Praveen B Raju, MD, PhD Email Praveen Raju
- SENIOR FACULTY | Neurology
- SENIOR FACULTY | Pediatrics
- Pediatric Neurology
- Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai Morningside and Mount Sinai West
- Developmental Disabilities Center 212-523-6230 212-523-6230
Praveen B. Raju, MD, PhD is a pediatric neurologist with board certification in Neurology with Special Qualifications in Child Neurology.
Dr. Raju completed his MD in 2001 at the University of Pennsylvania School of Medicine, where he also completed his PhD in Cell and Molecular Biology / Genetics as an NIH-funded MSTP Fellow. He served as a resident in Pediatrics at Babies & Children's Hospital of New York / Columbia-Presbyterian Medical Center and subsequently finished his Pediatric Neurology Fellowship training at Boston Children's Hospital / Harvard Medical School in 2006 where he served as Chief Fellow during his final year.
Following his clinical training, Dr. Raju was selected for the NIH-funded Pediatric Scientist Development Program (PSDP) where he completed advanced research training in mouse genetics at Memorial Sloan Kettering Cancer Center. Prior to joining the Icahn School of Medicine at Mount Sinai, he served on the faculty at Weill Cornell Medical College for 10 years where he received the Caryl & Israel A. Englander Clinical Scholar in Children’s Health Award and also cared for children with neurological issues on the Pediatric Cancer Service at Memorial Sloan Kettering Cancer Center.
At Mount Sinai Kravis Children's Hospital, Dr. Raju's primary clinical focus in pediatric onco-neurology treats patients with neurological complications of cancer including seizures, headaches, and neuropathy. In addition, his clinic has a special interest in pediatric neurofibromatosis (NF) and pediatric neurogenetic disorders.
In addition to his clinical responsibilities, Dr. Raju directs the Laboratory for Pediatric Brain Tumor Research at ISMMS and studies the developmental origins of pediatric brain tumors with a particular focus on medulloblastoma and its relationship to developmental signal transduction pathways. He is also the Director of the Mount Sinai Pediatric Neurology Residency Program.
Child Neurology, American Board of Psychiatry and Neurology
- Abnormally Large Head / Macrocephaly
- Acute Cerebellar Ataxia
- Arteriovenous Malformations
- Bell's Palsy
- Brain / Nervous System Cancer
- Brain Aneurysm
- Brain Malformation
- Brain Tumors
- Lumbar Puncture
- Movement Disorders
- Seizure Disorder
MD,PHD, University of Pennsylvania School of Medicine
Fellowship, Child Neurology
Children's Hospital Boston
Alex's Lemonade Stand Foundation
Hyundai Hope on Wheels Foundation
The Hartwell Foundation
Caryl & Israel A. Englander Clinical Scholar in Children’s Health
Weill-Cornell Medical College
George Von L. Meyer Award
Boston Children's Hospital
Pediatric Brain Tumors
Dr. Raju directs the Laboratory for Pediatric Brain Tumor Research at ISMMS and studies the developmental origins of pediatric brain tumors with a particular focus on medulloblastoma and its relationship to developmental signal transduction pathways. Through the utilization of sophisticated mouse genetics techniques, Dr. Raju and his team are creating new and improved preclinical mouse models of these childhood brain tumors to better understand their biology, investigate novel treatment approaches, as well as identify treatment resistance mechanisms that can be translated back for use in patients in order to improve their outcomes. Dr. Raju's research program has received support from the NIH/NINDS, NIH/NICHD, Department of Defense (DOD), STARR Cancer Consortium, St. Baldrick's Foundation for Childhood Cancer, Hartwell Foundation for Pediatric Research, American Brain Tumor Association, Unravel Pediatric Cancer Foundation, Hyundai Hope on Wheels Foundation, and Alex's Lemonade Stand Foundation for Childhood Cancer Research.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Raju did not report having any of the following types of financial relationships with industry during 2019 and/or 2020: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.